COO

The Cooper Companies, Inc.

Healthcare
59.49 -0.70 -1.16% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 11.61B
EV —
Shares Out 195.11M
Revenue (ttm) 4.15B
Net Income 401.40M
Beta —
P/E 28.80
Forward P/E —
EPS (ttm) $2.01
P/S —
P/B 1.39
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 3.23%
ROE 4.82%
ROIC —
Gross Margin 65.44%
Oper. Margin 17.19%
Profit Margin 9.67%
Debt/Eq 0.30
LT Debt/Eq 18.33%
Quick Ratio —
Current Ratio 1.34
Book/sh 42.72
Cash/sh 0.64
Div Yield 0.05%
Div TTM $0.03
Payout Ratio 1.49%
SMA20 -2.17%
SMA50 -8.98%
SMA200 -18.51%
Volume 4,196,217
Avg Volume 2.15M
Rel Volume —
Perf Week -2.81%
Perf Month -2.87%
Perf Quarter -25.82%
Perf Half Y -26.92%
Perf YTD -27.42%
Perf Year -16.42%
Perf 3Y -32.70%
Perf 5Y -37.70%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.0075
TTM Yield 0.05%
TTM Amount $0.03
Payout Ratio 1.49%
3-Yr Growth (CAGR) 10.06%
5-Yr Growth (CAGR) —

Last 12 Payouts

Period Ex-Date Amount / Share
Q3 2023 ~2023-07-31 $0.0075
Q2 2023 ~2023-02-10 $0.0075
Q1 2022 ~2023-01-31 $0.0075
Q3 2022 ~2022-08-11 $0.0075
Q3 2022 ~2022-07-31 $0.0075
Q2 2022 ~2022-02-09 $0.0075
Q1 2021 ~2022-01-31 $0.0075
Q3 2021 ~2021-08-11 $0.0075
Q3 2021 ~2021-07-31 $0.0075
Q2 2021 ~2021-02-09 $0.0075
Q1 2020 ~2021-01-31 $0.0075
Q3 2020 ~2020-08-07 $0.0075

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

The Cooper Companies, Inc. is a leading global medical device company headquartered in San Ramon, California, operating in over 130 countries and positively impacting over 50 million lives each year. The company operates through two business segments: CooperVision and CooperSurgical. CooperVision is a global manufacturer providing a broad range of contact lens products for vision correction, including single-use, two-week and monthly lenses featuring advanced silicone hydrogel materials. CooperVision's product portfolio addresses vision challenges such as astigmatism, presbyopia and myopia, offering spherical, toric and multifocal lenses, as well as specialty products like orthokeratology lenses and myopia management products, including the FDA-approved MiSight 1 day lens for slowing myopia progression in children. CooperSurgical offers a diversified portfolio focused on fertility and women's health, including medical devices for gynecology and obstetrics, fertility products and services, cryostorage services for cord blood and tissue, and contraception products. CooperSurgical serves multiple healthcare delivery points including OB/GYN medical offices, hospitals, ambulatory surgery centers, and fertility clinics. The company has established major manufacturing and distribution facilities in Belgium, Costa Rica, Hungary, Puerto Rico, the United Kingdom, the Netherlands, and the United States, with additional smaller facilities globally.

Name
The Cooper Companies, Inc.
Industry
Medical Instruments & Supplies
CEO
Albert G. White III · President and Chief Executive Officer
Employees
—
IPO Date
2012-12-28
Phone
(925) 460-3600
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA 94583
Website
https://www.coopercos.com

Key Executives

Name Title FY Pay
Colleen E. Jay Chairman of the Board —
Daniel G. McBride Executive Vice President, Chief Operating Officer, General Counsel and Secretary —
Albert G. White III President and Chief Executive Officer —

Latest News